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Abstract
Purpose: The aim of this investigation was to measure the gain in DVH indiceswhen the recently developed MLC was used for Cobalt-60 treatments. Methods: Aprototype multileaf collimator (MLC) that was retrofitted to telecobalt-60 therapymachine was reported and is currently proposed for clinical trials in ourinstitution. Ten patients’ plans that were previously planned through an ECLIPSE®treatment planning system and were treated with open beams from Cobalt-60machine were imported into Radiation Oncology Planning System [ROPS] and thedose calculations and dose volume histogram (DVH) analysis were performed. Theplans were re-planned using the Cobalt-MLC, a feature available in the ROPSplanning system. The DVH analysis consisted of conformity index (CI),homogeneity index (HI) and conformation number (CN). The results of this studyare presented in this paper. The analysis specifically aimed at measuring the gain inthese indices when the MLC was compared with open beams. Results: DVHComparison of ten sites using open and Cobalt MLC fields showed that the use ofMLC results in reduced normal tissue dose, while maintaining the GTV dose. Lowervalue of CI for normal structures was observed demonstrating the sparing ofcritical organs when MLC was used. The index HI was studied to show thesignificance of hot spots outside the PTV. Hot spots were observed even with MLCbeams for some cases due to less number of fields. Conclusion: It has beendemonstrated through DVH analysis that the use of the recently developed MLC forCobalt Teletherapy machine results in benefit for the treatment of patients.
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1. IntroductionCobalt-60 treatment machines are still used indeveloping countries all over the world. In India thereare over 200 Co-60 machines are still in operational.Unfortunately, these centers are operating in rural areaswith economic disadvantage and hence cannot affordmodern treatment planning or custom block fabrication.In a recent review in the red journal, Page et al.1 hascited the benefit of using multileaf collimator (MLC) tomake Co-60 treatments on a par with high energytreatment machines. The benefit of using MLC forcobalt-60 was also referred by several investigators2-8.The overall goal of our MLC project is not only todevelop the MLC as a retrofit attachment to the existing
cobalt machines, but also to provide a controller and alow cost treatment planning system (TPS) such asRadiation Oncology Planning System [ROPS] from TJCS(Tirumala Jyothi Computer Systems, Secunderabad,India).The MLC for Cobalt-60 used in our investigation waspreviously reported through a Monte Carlo study9-12,which had 14 leaf pairs to cover a treatment area of 14cm ×14 cm field size. Figure1 shows the Cobalt machineand the attached MLC.
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Subsequently, another prototype with 16 leaves to covera treatment area of 16 cm × 14 cm field size wasfabricated and was used in the current study. Thetungsten leaves with dimensions 7 mm wide, 4 cm highand 15 cm long with 2 cm × 2 mm tongue and groovewere used. All patient plans reported here were doneusing dedicated CT scanner with interface to Eclipse TPSfrom Varian (Varian Medical Systems, Palo Alto, CA). TheCT scans and complete plans from Eclipse TPS wereavailable for export through DICOM RT files.
2. Methods and MaterialsTen different cases representing each of the tumor siteslike Brain, Head & Neck, Esophagus, Stomach, Abdomenand Pelvis were taken for the study. These cases wereoriginally planned in Eclipse treatment system andtreated accordingly with open beams of Cobalt-60 unit.All the cases were re-planned in ROPS treatmentplanning system with MLC beams fitted to the PTV. Foreach case, DVH data were obtained for both plans (openand MLC beams).The ROPS TPS is specially configured for the Cobalt MLCto adjust the MLC leaves around the irregular shape ofthe target with margin as well as exporting the leafpositions to the MLC controller. Since the controller isindigenously developed with hardware and software,ROPS is the only TPS that can be configured to match theMLC controller. The ROPS TPS was previously testedwith TG-53 protocol13. This is a part of accepting testingand commissioning of TPS, which verified PDD, profiles,contour corrections, irregular fields and wedge profiles.In addition, the ROPS TPS was compared with EclipseTPS by using 6 MV and 16 MV plans14.For each clinical case the tumor volumes, criticalstructures and beam parameters were imported fromthe Eclipse planning system using DICOM_RT transfer.For cobalt treatment, in general 1-1.5 cm margin wasused around the clinical target volume (CTV) to makethe planning target volume (PTV). If CTV is not defined,then the gross tumor volume (GTV) is chosen as thetarget of importance. Since there was no asymmetric jawor MLC available for the cobalt machine, the beamboundaries in Eclipse plans covered the PTV using thecollimator jaws only. In the current study, since we have
the MLC for cobalt machine, the original open beamplans were compared by using the MLC to fit the PTV.The DVH analysis was carried out by computing threeindices viz. conformity index (CI), homogeneity index(HI) and conformation number (CN).
 The conformity index (CI) was determined asthe ratio between target volume covered by the90% or 95% isodose and the target volume(TV). While 95% isodose line is used as astandard isodose line for the definition of theindices, for cobalt-60, we have also considered90% isodose line since 95% cannot cover theTV in some cases.
 The homogeneity index (HI) was determined asthe ratio of maximum dose in the target volumeto the prescription dose.
 The conformation number (CN) was defined byArie van't Riet et al.15 and was calculated usingthe formula:CN= (TViso /TV) (TViso / Viso),where, TViso is the target volume covered by theisodose line, TV is the target volume and Viso isthe total volume covered by the 90% or 95%isodose line. The Viso is calculated from the dosematrix and is not dependent on any structurevolume. The advantage of these indices is thatideally the values need to be close to unity forthe CTV or GTV while the values should be closeto zero for other structures.The CN shows that the MLC confines the dose to PTV.The value of CI close to unity for the GTV indicates thatthe dose uniformity of the target is achieved. Since theuse of MLC decreases dose to the critical structures,lower values of CI should be expected when comparedwith open beam. The value of HI close to unity for theGTV indicates that there are no hotspots. However, forcertain 3-field plans using Cobalt beams the doseoutside the PTV causes HI > 1 especially for abdomenand pelvic sites.
Figure 1: Prototype 1 MLC configured in ROPS TPS(reprinted with permission from Ayyangar et al.10)
3. ResultsFigure 2 shows the DVH Comparison of a cervix caseusing open and Cobalt MLC fields. It can be seen that theuse of MLC results in reduced normal tissue dose, whilemaintaining the GTV dose. Similar comparisons for brainand esophagus sites are shown in Figures 3 and 4respectively. A typical beam arrangement from the ROPS3D planning system for a three-field brain case with MLCfields is shown in Figure 5.
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Figure 2: A Case of cervix treatment showing DVHComparison of MLC vs. OPEN fields. Thick lines are for MLCand thin lines for OPEN beams.
Figure 3: A Case of brain treatment showing DVHComparison of MLC vs. Open fields. Thick lines are for MLCand thin lines for OPEN beams.
Figure 4: A Case of esophagus treatment showing DVHComparison of MLC vs. Open fields. Thick lines are for MLCand thin lines for OPEN beams.Table 1 shows conformity index CI for the GTV. It can beseen that both the open and MLC plans cover the GTVadequately. Due to large or irregular target shape,sometimes the 95% isodose line did not cover even theGTV adequately. In this case, the 90% isodose line
covered adequately. This can be evident in the clinical ofcase #5 in Table 1.The CI for critical structure is tabulated in Table 2. It canbe seen that the MLC plan showed lower valuecompared to open beam plan. Once again, a low CI forstructures other than the target is desirable.
Figure 5: A typical MLC beam arrangement from the ROPS3D planning system for a three field brain treatment isshown here.The homogeneity index HI is tabulated in Table 3. Thehomogeneity index signifies the hot spot in the targetvolume. A value higher than 1 is undesirable since thatsignifies the dose outside the GTV is larger than themaximum dose in the target volume. It can be seen fromtable 3 that for clinical cases 4, 5, 8, 10, the hotspot islarger than in the target volume. This usually happensfor three field plans and can be reduced by adding morefields. In this study, our goal was to compare withalready treated plans and hence the plans were notmodified.
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Table 2: Conformity Index of critical structures.Case# Structure Open MLC Open MLCCI95% CI95% CI90% CI90%1 Rectum 0.79 0.48 0.83 0.54Bladder 0.41 0.16 0.46 0.22 Rectum 0.79 0.25 0.83 0.3Bladder 1 0.54 1 0.553 Rectum 0.83 0.25 0.91 0.35Bladder 0.45 0.04 0.47 0.044 Spinal Cord 0.17 0.03 0.21 0.06Heart 0.38 0 0.47 0
5 Spinal Cord 0 0 0.2 0Lt. Kidney 0.07 0 0.38 0Rt. Kidney 0.33 0 0.36 06 Spinal Cord 0.02 0 0.05 07 Spinal Cord 0.43 0.03 0.54 0.078 OpticNerve 0.99 0.14 0.99 0.149 Spinal Cord 0.18 0.05 0.28 0.0910 Spinal Cord 0.66 0.04 0.83 0.05Open means without the use of MLC
Table 3: Homogeneity Index for GTV.Homogeneity IndexCase # Open MLC1 1.01 1.012 1.01 1.013 1.01 1.014 1.14 1.205 1.12 1.156 1.03 1.037 1.05 1.078 1.11 1.109 0.97 0.8910 1.11 1.20Open means without the use of MLCLastly, Table 4 shows the results of conformationnumber CN. Even after using 3D plans, the conformationnumber was not close to unity. This is because isodosecannot conform an irregular shape of the target, unlessmany beams, 3D dose compensators and non-coplanarbeam arrangements are used. However, markedimprovement in CN can be noticed by using the MLCcompared to open beams. The 90% isodose line resultedin better CN values compared to 95% isodose line.
Table 4: Conformation Number for PTV.Case # Open MLC Open MLCCN 95 CN 95 CN 90 CN 901 0.425 0.590 0.475 0.9832 0.258 0.669 0.317 0.8533 0.223 0.526 0.312 0.7914 0.238 0.543 0.294 0.6575 0.166 0.346 0.317 0.8046 0.418 0.521 0.638 0.9597 0.306 0.592 0.471 0.9338 0.373 0.555 0.503 0.8649 0.323 0.359 0.512 0.54810 0.211 0.670 0.244 0.743Open means without the use of MLC
4. DiscussionIn conventional Telecobalt treatments, patients weretreated with open beams, as a consequence of whichconsiderable dose to normal structures are inevitable.It was unavoidable in order to treat the target volumes.Unfortunately, this leads to normal tissue complicationsfor most of organs that were exposed to higher doses. Byusing shielding blocks, it takes more time to plan a caseand for setting up the patient to treat. Also, there is noclear idea about the coverage of PTV and dose to normalstructures. Having dedicated treatment planning (ROPS)to control the add-on MLC for existing telecobalt-60treatment units, it is very easy to plan and treat therequired PTV and at the same time, normal organs canbe spared. This reduces the normal tissue complicationsfor the patients. This has been shown by adding MLC toexisting Telecobalt machines, the same treatments werere-planned in new ROPS treatment planning system.This study showed that a better target coverage andsignificant dose reduction to OARs could be achievedwith the use of MLC.
5. ConclusionBy studying the DVH indices like conformity index,homogeneity index and conformation number, it hasbeen shown that the values of these indices are in favorof MLC beam plans compared to that of open beams.Instead of treating the patients with open beams on oldCo-60 units where there is no scope for the modificationof the units, it is better to have add-on MLC for themachines. And, it has been demonstrated through DVHanalysis that the use of the MLC for Cobalt Teletherapymachine results in benefit for the treatment of patients.
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